LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Large Genome-Wide Association Study Identifies Novel Abdominal Aortic Aneurysm Risk Loci

By LabMedica International staff writers
Posted on 05 Oct 2020
Image: Illustration of the heart with magnification of the artery (Photo courtesy of American Heart Association)
Image: Illustration of the heart with magnification of the artery (Photo courtesy of American Heart Association)
A recent report identified novel genetic associations for abdominal aortic aneurysm (AAA) with therapeutic implications and identified a subset of the population at significantly increased genetic risk of AAA that was independent of family history.

AAA is a localized enlargement of the abdominal aorta such that the diameter is greater than three centimeters or more than 50% larger than normal. They usually cause no symptoms, except during rupture. Rupture may result in pain in the abdomen or back, low blood pressure, or loss of consciousness, and often results in death. AAAs occur most commonly in men over 50 years old, and among those with a family history. Additional risk factors include smoking, high blood pressure, and other heart or blood vessel diseases. AAAs are the most common form of aortic aneurysm. In the United States, screening with abdominal ultrasound is recommended for males between 65 and 75 years of age with a history of smoking. The genetic determinants of AAA remain incompletely defined. In total, 10 previously identified risk loci explain only a small fraction of the inheritance of AAA.

Investigators at Stanford University (Palo Alto, CA, USA) and a large number of collaborators from other institutions performed a genome-wide association study (GWAS) on samples obtained from the Million Veteran Program. This program, which was initiated in 2011 and is now one of the world's largest genetic biobanks, was designed to promote the study of how genes affect the health of United States military veterans.

For the current study, the investigators performed a GWAS on nearly 18 million DNA sequence variants with AAA (7,642 cases and 172,172 controls) in veterans of European ancestry with independent replication in up to 4,972 cases and 99,858 controls. They then used Mendelian randomization to examine the causal effects of blood pressure on AAA. In addition, they examined the association of AAA risk variants with aneurysms in the lower extremity, cerebral, and iliac arterial beds, and derived a genome-wide polygenic risk score (PRS) to identify a subset of the population at greater risk for the disease.

Results revealed 14 novel genetic loci, bringing the total number of known significant AAA loci to 24. A genetic-linked increase of 10 millimeters of mercury (Hg) in diastolic blood pressure increased the risk of developing abdominal aortic aneurysm. Analysis showed further that 19 of the 24 risk loci for AAA were associated with aneurysms in other parts of the body. A 29-variant PRS was strongly associated with AAA, independent of family history and smoking risk factors. Using this PRS, the investigators identified a subset of the population with AAA prevalence greater than that observed in screening trials performed according to current guidelines.

"This study has doubled the number of genetic associations with abdominal aortic aneurysm, adding greatly to our understanding of the disease mechanisms," said senior author Dr. Philip S. Tsao, professor of cardiovascular medicine at Stanford University. "We were surprised that diastolic blood pressure, as opposed to systolic blood pressure, is likely of greater significance in the development of abdominal aortic aneurysm. This new information can enhance screening protocols and help identify individuals at risk for abdominal aortic aneurysm."

The AAA study was published in the September 28, 2020, online edition of the journal Circulation.

Related Links:
Stanford University

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Laboratory Software
ArtelWare

Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more